Randomized Trial Comparing Type-I Collagen-Based Skin Substitute and Fish Skin Matrix for Diabetic Foot Ulcers
Led by Adichunchanagiri Institute of Medical Sciences, B G Nagara · Updated on 2026-09-10
120
Participants Needed
4
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates the treatment of diabetic foot ulcers DFUs by comparing two skin substitutes a high-purity type-I collagen-based skin substitute HPTC and an acellular intact fish skin matrix AFSM. The study enrolls patients with Wagner Grade 1-2 diabetic foot ulcers to evaluate which treatment, combined with standard wound care, leads to better healing outcomes. This randomized controlled clinical trial is conducted at multiple centers in India and Bangladesh to assess safety and effectiveness.
Participants are randomly assigned to receive either HPTC or AFSM, each applied weekly or as needed, followed by a padded 3-layer dressing that includes non-adherent paraffin gauze, absorbent gauze pads, and a soft crepe bandage. Some participants may join an optional sub-study involving small biopsies from the wound edge for detailed tissue analysis. The primary outcome is the proportion of participants achieving complete wound closure by Week 12, with assessments confirmed about a week later.
During the trial, participants attend scheduled visits where wound healing is closely monitored through digital imaging and expert evaluation. Additional measurements include wound area reduction over time, scar quality, quality of life, and ulcer recurrence up to Week 13. Safety is tracked by recording any adverse events, and participants must follow prescribed off-loading methods and attend all study visits. The total participation duration is approximately 13 weeks from treatment start to final assessment.
CONDITIONS
Brief Title
HPTC Versus AFSM in Diabetic Foot Ulcers
Research Team
N
Naveen Narayan
C
Chethan Shivannaiah
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Adichunchanagiri Institute of Medical Sciences, B G Nagara
Lead Sponsor
Mysore Medical College and Research Institute, Mysurur
Collaborating Sponsor
Who Can Participate
Age: 18Years - 75Years
All Genders
Eligibility Criteria
You may qualify if you...
Subjects must be at least 18 years of age or older.
Subjects must have a diagnosis of type 1 or 2 diabetes mellitus.
Diabetic foot ulcer located below the malleoli, Wagner Grade 1 or 2, without exposed bone.
Target ulcer present for a minimum of 4 weeks, with post-debridement area of approximately 5-20 cm².
Failure to achieve ≥30% ulcer-area reduction during the run-in period, or an equivalent documented waiver.
Adequate circulation to the affected foot: ankle-brachial index between 0.7 and 1.3 or alternative vascular criteria.
Glycated haemoglobin (HbA1c) ≤ 12%.
Consent to using the prescribed off-loading method for the study duration.
Agreement to attend scheduled study visits.
Willingness and ability to participate in the informed consent process.
Signed informed consent form before screening procedures.
You will not qualify if you...
Life expectancy less than 6 months.
Target ulcer is infected or has surrounding cellulitis.
Presence of osteomyelitis or exposed bone, or Wagner Grade ≥3 ulcer.
Infection in the target ulcer requiring systemic antibiotics.
Receiving immunosuppressants or cytotoxic chemotherapy.
Topical steroid use on ulcer within one month before screening.
Previous partial amputation on affected foot causing improper offloading.
Glycated haemoglobin (HbA1c) greater than 12% at or within 3 months before screening.
Acute or inactive Charcot foot impeding offloading.
Women who are pregnant or planning pregnancy within 6 months.
End-stage renal disease requiring dialysis or active malignancy.
Participation in another investigational treatment trial within 30 days.
Medical or psychological conditions interfering with study assessments.
Treatment with hyperbaric oxygen or cellular/tissue products within 30 days.
Known hypersensitivity to HPTC or fish allergy for relevant treatment groups.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to 13 weeks
Participants receive either the high-purity collagen skin substitute or the fish skin matrix along with standardized wound care dressings applied weekly or as needed.
Weekly visits for wound assessment and dressing changes
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Clinical Trial Evaluating Xcell Amnio Matrix with Standard Treatment for Diabetic Foot Ulcers in Adults
Randomized Trial Comparing VES-0-D Gel Versus Standard Care for Mild to Moderate Diabetic Foot Ulcers Over 8 Weeks
Multicenter Study Comparing Tri-Layer and Single-Layer Amnion Grafts for Healing Hard-to-Heal Diabetic Foot and Venous Leg Ulcers
Comparing Two Wound Care Devices to Standard Treatment for Hard-to-Heal Diabetic Foot and Venous Leg Ulcers
Pilot Study of CARE-D-Foot-Nav Patient Navigator Program to Support Healing in Diabetic Foot Ulcer Patients
Comparison of Bionerv E Versus Vitamin B-Complex for Treatment of Diabetic Polyneuropathy and Effects on Wound Healing in Type 2 Diabetes
Evaluation of CYWC628 with Standard Care for Treating Refractory Diabetic Foot Ulcers Compared to Standard Care Alone
Evaluating the DiaFootCare Mobile App for Supporting Self-Care and Monitoring of Diabetic Foot Ulcers Compared to Usual Care in Oman
Coordinated Multidisciplinary Team Care Versus Standard Treatment for Adults with Hard-to-Heal Ulcers
Evaluating Amnio-Maxx Dual Layer Amnion Patch with Standard Care for Healing Chronic Diabetic Foot Ulcers
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers.
Eric J Lullove, Brock Liden, Christopher Winters...
Final efficacy and cost analysis of a fish skin graft vs standard of care in the management of chronic diabetic foot ulcers: a prospective, multicenter, randomized controlled clinical trial.
A Randomized Controlled Clinical Trial Comparing the Use of High Purity Type-I Collagen-Based Skin Substitute vs. Dehydrated Human Amnion/Chorion Membrane in the Treatment of Diabetic Foot Ulcers.
Comparative Efficacy of High Purity Type I Collagen-Based Skin Substitute and Dehydrated Human Amnion/Chorion Membrane in Diabetic Foot Ulcers: A Multicentre Randomized Controlled Trial.